Intended for healthcare professionals

News

Five minutes with . . . Andrew Pollard, chair of JCVI

BMJ 2016; 352 doi: https://doi.org/10.1136/bmj.i1098 (Published 23 February 2016) Cite this as: BMJ 2016;352:i1098
  1. Susan Mayor,
  2. freelance journalist
  1. London

The chair of the UK Joint Committee on Vaccination and Immunisation explains the decision to limit the meningitis B vaccine to infants under 1 year old, as a petition calling for it to be offered to children up to 11 gains nearly three quarters of a million signatories1

“The amount and severity of a disease are the most important factors that drive vaccination decisions. Invasive meningococcal disease due to capsular group B meningococcus (MenB) infection is rare and has decreased significantly over the last decade for …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription